ZA201403574B - Methods for treating gout in patient subpopulations - Google Patents

Methods for treating gout in patient subpopulations

Info

Publication number
ZA201403574B
ZA201403574B ZA2014/03574A ZA201403574A ZA201403574B ZA 201403574 B ZA201403574 B ZA 201403574B ZA 2014/03574 A ZA2014/03574 A ZA 2014/03574A ZA 201403574 A ZA201403574 A ZA 201403574A ZA 201403574 B ZA201403574 B ZA 201403574B
Authority
ZA
South Africa
Prior art keywords
methods
treating gout
patient subpopulations
subpopulations
patient
Prior art date
Application number
ZA2014/03574A
Inventor
A Mcwherter Charles
K Roberts Brian
chandra saha Gopal
Edward Lavan Brian
Original Assignee
Cymabay Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cymabay Therapeutics Inc filed Critical Cymabay Therapeutics Inc
Publication of ZA201403574B publication Critical patent/ZA201403574B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2014/03574A 2011-11-04 2014-05-16 Methods for treating gout in patient subpopulations ZA201403574B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/059425 WO2013066352A1 (en) 2011-11-04 2011-11-04 Methods for treating gout in patient subpopulations

Publications (1)

Publication Number Publication Date
ZA201403574B true ZA201403574B (en) 2015-11-25

Family

ID=48192536

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/03574A ZA201403574B (en) 2011-11-04 2014-05-16 Methods for treating gout in patient subpopulations

Country Status (14)

Country Link
EP (1) EP2775835A4 (en)
JP (1) JP6047172B2 (en)
KR (1) KR101848122B1 (en)
CN (1) CN104066323A (en)
AU (1) AU2011380509B2 (en)
BR (1) BR112014010693A2 (en)
CA (1) CA2859689C (en)
CL (1) CL2014001156A1 (en)
IL (1) IL232385A (en)
MX (1) MX354846B (en)
NZ (1) NZ624714A (en)
SG (1) SG11201402027PA (en)
WO (1) WO2013066352A1 (en)
ZA (1) ZA201403574B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150002799A (en) * 2012-04-13 2015-01-07 사이머베이 쎄라퓨틱스, 인코퍼레이티드 Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent
CN104068288B (en) * 2014-07-25 2016-08-24 许伟琦 A kind of feed additive of anti-lithangiuria
CN105920022A (en) * 2016-05-12 2016-09-07 成都易创思生物科技有限公司 Anti-gout medicinal compound preparation
JP7086980B2 (en) * 2017-10-26 2022-06-20 大塚製薬株式会社 Inositol phosphate-containing composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250191A (en) * 1978-11-30 1981-02-10 Edwards K David Preventing renal failure
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
TWI415840B (en) * 2007-11-27 2013-11-21 Ardea Biosciences Inc Novel compounds and compositions and methods of use

Also Published As

Publication number Publication date
KR101848122B1 (en) 2018-04-11
MX2014005399A (en) 2015-04-08
BR112014010693A2 (en) 2020-11-10
NZ624714A (en) 2016-01-29
SG11201402027PA (en) 2014-09-26
CA2859689C (en) 2018-05-22
CA2859689A1 (en) 2013-05-10
EP2775835A1 (en) 2014-09-17
MX354846B (en) 2018-03-22
IL232385A (en) 2017-10-31
IL232385A0 (en) 2014-06-30
WO2013066352A1 (en) 2013-05-10
JP6047172B2 (en) 2016-12-21
KR20140123927A (en) 2014-10-23
AU2011380509B2 (en) 2016-05-19
EP2775835A4 (en) 2015-07-29
CN104066323A (en) 2014-09-24
JP2014532759A (en) 2014-12-08
CL2014001156A1 (en) 2015-01-16
AU2011380509A1 (en) 2014-05-29

Similar Documents

Publication Publication Date Title
HUE045988T2 (en) Sliding-type apparatus for thermotherapeutic treatment
EP2671086A4 (en) System and method for diagnosis and treatment
LT3412687T (en) Methods for treating dlbcl
EP2531625A4 (en) Method for treating tailings
ZA201208219B (en) Method for treating wasterwater
IL220594A0 (en) Treatment method
EP2631461A4 (en) Fuel magnetization treatment method
SG11201401981TA (en) Methods for treating gout flares
EP2735250A4 (en) Sliding-type apparatus for thermotherapeutic treatment
ZA201403574B (en) Methods for treating gout in patient subpopulations
EP2536282A4 (en) Methods for treating infection
GB201105523D0 (en) Treatment method
EP2704731A4 (en) Avian-based treatment
EP2813798A4 (en) Blast treatment method
EP2768536A4 (en) Method for treating type i and type ii diabetes
SG11201403180YA (en) Improvements in machining apparatus
GB201109796D0 (en) Treatment device
GB201102265D0 (en) Treatment
GB201102263D0 (en) Treatment
GB201102274D0 (en) Treatment
GB201102268D0 (en) Treatment
GB201102275D0 (en) Treatment
GB201102267D0 (en) Treatment
GB201102276D0 (en) Treatment
GB201102270D0 (en) Treatment